“Early Changes in Patient-Relevant Endpoints in Three Tralokinumab Pivotal Phase 3 Trials (ECZTRA 1−3) in Adult Patients With Moderate-to-Severe Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s98. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1068.